Here are five facts:
1. Actifuse Flow is a prepackaged delivery syringe designed for use in pelvis, extremities and posterolateral spine orthopedic surgeries.
2. The graft substitute temporarily fills in the bone and is eventually replaced by the patient’s own bone during the healing process.
3. The syringe design facilitates precise positioning for filling small bone defects and complex gaps. The graft will be available in 1.5 ml, 3 ml and 5 ml sizes.
4. Baxter plans to launch Actifuse Flow commercially within the coming months.
5. Actifuse Flow is part of Baxter’s osteobiologics surgery portfolio, along with Actifuse ABX, Actifuse Shape, Actifuse MIS and Altapore. The products use silicate-substituted technology to increase silicon levels for bone formation.
More articles on supply chain:
ASC supply chain tip of the day: Monitor key performance metrics
ASC supply chain tip of the day: Reduce waste
3 Ways to cut operating room inventory in an ASC
